Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
暂无分享,去创建一个
N. Malats | M. Márquez | A. Carrato | A. Tardón | F. Real | P. Gómez-Rubio | J. Kleeff | M. Hidalgo | W. Greenhalf | Eithne Costello | A. Scarpa | R. Lawlor | T. Gress | C. Michalski | L. Sharp | H. Renz | M. Löhr | X. Molero | W. Ye | J. Mora | A. Farré | E. Molina-Montes | M. Rava | M. Iglesias | J. Dominguez-Munoz | T. Crnogorac-Jurcevic | B. Kong | L. Muñoz-Bellvís | M. O'Rorke | J. Perea | L. Ilzarbe | D. O’Driscoll | V. Barberá | Rianne Boenink | J. Balcells | I. Poves | Jingru Yu | C. Coscia | A. Fernández
[1] James D. Johnson,et al. Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development. , 2019, Cell metabolism.
[2] Kenneth A. Philbrick,et al. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. , 2019, Gastroenterology.
[3] James D. Johnson,et al. Endogenous insulin contributes to pancreatic cancer development , 2019, bioRxiv.
[4] Helen E. Parkinson,et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..
[5] C. Haiman,et al. Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort , 2018, Journal of the National Cancer Institute.
[6] T. Smyrk,et al. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis. , 2018, Gastroenterology.
[7] Albert C. Koong,et al. Altered exocrine function can drive adipose wasting in early pancreatic cancer , 2018, Nature.
[8] Valeriia Haberland,et al. The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.
[9] Melissa Matz,et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.
[10] D. Saur,et al. Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells. , 2018, Cancer letters.
[11] Tyler J. VanderWeele,et al. Sensitivity Analysis in Observational Research: Introducing the E-Value , 2017, Annals of Internal Medicine.
[12] Jessica M B Rees,et al. Extending the MR‐Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy , 2017, Statistics in medicine.
[13] S. Thompson,et al. Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.
[14] P. Brennan,et al. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study , 2017, Journal of the National Cancer Institute.
[15] Olena O Yavorska,et al. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.
[16] A. Rustgi,et al. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. , 2017, Gastroenterology.
[17] Zhengming Chen,et al. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta‐analysis of 22 cohort studies , 2017, International journal of cancer.
[18] J. Ferlay,et al. More deaths from pancreatic cancer than breast cancer in the EU by 2017 , 2016, Acta oncologica.
[19] C. D. De Block,et al. Diabetes mellitus and pre-diabetes are frequently undiagnosed and underreported in patients referred for pancreatic surgery. A prospective observational study. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[20] Stephen Burgess,et al. PhenoScanner: a database of human genotype–phenotype associations , 2016, Bioinform..
[21] Iain Buchan,et al. Collider Bias Is Only a Partial Explanation for the Obesity Paradox , 2016, Epidemiology.
[22] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[23] T. VanderWeele. Mediation Analysis: A Practitioner's Guide. , 2016, Annual review of public health.
[24] G. Davey Smith,et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies1 , 2016, The American journal of clinical nutrition.
[25] J. Connett,et al. Role of survivor bias in pancreatic cancer case-control studies. , 2016, Annals of epidemiology.
[26] N. Malats,et al. Reduced risk of pancreatic cancer associated with asthma and nasal allergies , 2015, Gut.
[27] Benjamin S. Glicksberg,et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity , 2015, Science Translational Medicine.
[28] Bao-sheng Wang,et al. Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis , 2015, PloS one.
[29] L. Levin,et al. Biodiversity on the Rocks: Macrofauna Inhabiting Authigenic Carbonate at Costa Rica Methane Seeps , 2015, PloS one.
[30] G. Petersen,et al. Do Variants Associated with Susceptibility to Pancreatic Cancer and Type 2 Diabetes Reciprocally Affect Risk? , 2015, PloS one.
[31] P. Maisonneuve,et al. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. , 2015, International journal of epidemiology.
[32] S. Thompson,et al. Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.
[33] Heng-Yi Wu,et al. Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature , 2014, PloS one.
[34] A. Butterworth,et al. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways , 2014, International journal of epidemiology.
[35] G. Honda,et al. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan. , 2014, World journal of gastroenterology.
[36] Zheng Wang,et al. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. , 2014, Diabetes research and clinical practice.
[37] A. Miller,et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] M. Reni,et al. Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients , 2014, Acta Diabetologica.
[39] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[40] S. Vander Hoorn,et al. Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies , 2014, Annals of surgical oncology.
[41] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[42] E. Riboli,et al. Genes–Environment Interactions in Obesity- and Diabetes-Associated Pancreatic Cancer: A GWAS Data Analysis , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[43] A. Butterworth,et al. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.
[44] P. Vigneri,et al. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[45] Suresh T. Chari,et al. New insights into pancreatic cancer-induced paraneoplastic diabetes , 2013, Nature Reviews Gastroenterology &Hepatology.
[46] Charles E McCulloch,et al. Estimation of covariate effects in generalized linear mixed models with a misspecified distribution of random intercepts and slopes , 2013, Statistics in medicine.
[47] S. Chari,et al. Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers , 2013, Pancreas.
[48] N. Sasahira,et al. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age , 2013, Journal of Gastroenterology.
[49] E. Riboli,et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort , 2011, Diabetologia.
[50] Jun Liu,et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. , 2011, European journal of cancer.
[51] Ananda Basu,et al. Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes Mellitus , 2011, Pancreas.
[52] B. Pierce,et al. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data , 2011, Cancer Causes & Control.
[53] Manal M. Hassan,et al. Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[54] M. Tobin,et al. Mendelian Randomisation and Causal Inference in Observational Epidemiology , 2008, PLoS medicine.
[55] Mariza de Andrade,et al. Probability of pancreatic cancer following diabetes: a population-based study. , 2005, Gastroenterology.
[56] R. Simon,et al. Flexible regression models with cubic splines. , 1989, Statistics in medicine.